Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

SELL
$1.22 - $40.8 $10,980 - $367,200
-9,000 Reduced 44.16%
11,381 $15,000
Q2 2022

Aug 11, 2022

BUY
$1.15 - $3.34 $10,350 - $30,060
9,000 Added 79.08%
20,381 $33,000
Q1 2022

May 13, 2022

SELL
$2.96 - $7.76 $3,566 - $9,350
-1,205 Reduced 9.57%
11,381 $35,000
Q4 2021

Feb 14, 2022

BUY
$7.4 - $11.66 $5,920 - $9,328
800 Added 6.79%
12,586 $93,000
Q3 2021

Nov 16, 2021

SELL
$9.18 - $14.15 $82,620 - $127,350
-9,000 Reduced 43.3%
11,786 $136,000
Q2 2021

Aug 13, 2021

BUY
$8.07 - $12.52 $6,334 - $9,828
785 Added 3.92%
20,786 $260,000
Q1 2021

May 17, 2021

BUY
$8.57 - $15.79 $26,309 - $48,475
3,070 Added 18.13%
20,001 $207,000
Q4 2020

Feb 17, 2021

BUY
$5.98 - $12.47 $13,455 - $28,057
2,250 Added 15.33%
16,931 $141,000
Q3 2020

Nov 13, 2020

BUY
$4.65 - $8.73 $68,266 - $128,165
14,681 New
14,681 $90,000

Others Institutions Holding DTIL

About PRECISION BIOSCIENCES INC


  • Ticker DTIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 110,818,000
  • Market Cap $539M
  • Description
  • Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...
More about DTIL
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.